Monogram Orthopaedics, Inc. (MGRM)
Monogram Orthopaedics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Austin, TX, US. The stock last traded at $6.00, down 1.80% on the session, giving a market capitalisation of $243.8M. On trailing twelve-month figures it carries a trailing P/E of -23.42, a net margin of 0.0%. Its beta of 0.69 implies it has historically moved less than the broad market.
Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.
Monogram Orthopaedics, Inc. is most often compared with the following Healthcare names: